Comparison Between Pulsed and Continuous Accelerated Corneal Cross-Linking Protocols
Mohamed Omar Yousif,Rania Serag Elkitkat,Noha Abdelsadek Alaarag,Mouamen Moustafa Seleet,Ashraf Hassan Soliman
DOI: https://doi.org/10.2147/OPTH.S409178
2023-05-16
Clinical Ophthalmology
Abstract:Mohamed Omar Yousif, 1, 2 Rania Serag Elkitkat, 1, 3– 5 Noha Abdelsadek Alaarag, 1 Mouamen Moustafa Seleet, 1 Ashraf Hassan Soliman 1 1 Ophthalmology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 2 Maadi Eye Subspecialty Center, Cairo, Egypt; 3 Watany Eye Hospitals, Cairo, Egypt; 4 Watany Research and Development Center, Cairo, Egypt; 5 Ophthalmology Department, Faculty of Medicine, MTI University, Cairo, Egypt Correspondence: Rania Serag Elkitkat, Email ; Purpose: To compare between two accelerated corneal cross-linking (A-CXL) protocols in the management of keratoconus (KC) as regard to the extent of corneal treatment. Methods: This retrospective, comparative study included patients having mild to moderate, progressive KC. The study population was divided into two groups; group 1 enrolled 103 eyes of 62 patients who received pulsed light A-CXL (pl-CXL) at a power of 30 mW/cm 2 with an irradiation time of 4 minutes, while group 2 comprised 87 eyes of 51 patients who received continuous light A-CXL (cl-CXL) at a power of 12 mW/cm 2 with an irradiation time of 10 minutes. Recordings of the central and peripheral demarcation line depths (DD), and the maximum (DDmax) and minimum (DDmin) DD, using anterior segment optical coherence tomography, were compared between the two studied groups one month after the treatment protocol. Treatment stability was also evaluated pre and postoperatively (one year following surgery) by comparing the refractive and keratometric outcomes in both groups. Results: The differences between the preoperative corneal thickness (minimum and central) and the epithelial thickness measurements between both groups were not statistically significant. Although group 1 had slightly larger central DD (223.4 ± 62.3 um), DDmax (240.4 ± 61.8 um), and DDmin (201 ± 54 um) than those of group 2 (221.8 ± 37 um, 229.1 ± 38.4 um, and 212 ± 37.2 um, respectively), the differences between both groups' measurements were not statistically significant. Also, the two groups showed statistically insignificant differences regarding the subjective refraction and the average and maximum keratometry pre and postoperatively, denoting visual, refractive, and keratometric stability in both groups. Conclusion: Longer duration cl-CXL seems to be as effective as pl-CXL regarding both postoperative stability and the extent of corneal tissue penetration by the ultraviolet treatment. Keywords: keratoconus, corneal cross-linking, demarcation line anterior segment OCT, pulsed light corneal cross-linking, ultraviolet A corneal cross-linking Keratoconus (KC) is the most prevalent primary corneal ectasia and is characterized by progressive corneal thinning and steepening, visual distortion, and eventual central corneal scarring. 1 The disease is often manifested in the second decade of life due to both genetic and environmental contributions, with recognized risk factors that include ocular allergy, eye rubbing, a positive family history, an Arabian or Asian ethnicity, and syndromic co-occurrences as Down, Ehlers–Danlos, and Marfan syndromes. 2 Various management options for KC are available depending on the stage of the disorder and the goal of intervention. 3 Eyeglasses and contact lenses are suitable for correction of refractive errors in the early stages in cases with stationary course, mainly with older ages. Implantable intrastromal corneal ring segments (ICRS) are useful for flattening the cornea and reducing aberrations, while surgical grafting of partial- or full-thickness corneal tissue is often the only option in advanced disease. 4 Corneal collagen cross-linking (CXL) is a relatively recent procedure that has been established as a safe and effective means for halting the progression of KC. 5,6 The intervention entails the administration of ultraviolet A (UVA) radiation (wavelength: 365 nm) in conjunction with riboflavin (vitamin B2) to the corneal surface, leading to a photochemical reaction which generates reactive oxygen species and new covalent bonds between the stromal collagen fibers, with an end result of increased corneal biomechanical strength. 7,8 The standard protocol for CXL (also known as Dresden protocol or conventional CXL) has raised concerns regarding the long duration of treatment, higher rate of complications, and possibility of overtreatment, and has, thus, been largely replaced by newer accelerated protocols (A-CXL). 9 Such protocols administer higher powers along shorter time intervals, while preserving constant delivery of total energy dose (TED). 10,11 This is possible -Abstract Truncated-